Cost-minimisation analysis of sequential treatment with ofloxacin or ciprofloxacin in hospitalised patients

PharmacoEconomics

Volumn 11, Issue 4, 1997, Pages 359-366

  Salewski, Erich ^a   Bassaris, Harry P ^b   Calangu, Semra ^c   Kitzes, Ruth ^d   Kosmidis, John ^e   Raz, Raul ^f   Kompan, Lidija ^g  

^a SANOFI   (France)

^b UNIVERSITY OF PATRAS   (Greece)

^c ISTANBUL UNIVERSITY   (Turkey)

^d CARMEL MEDICAL CENTER   (Israel)

^e KAT HOSPITAL   (Greece)

^f HAEMEK MEDICAL CENTER   (Israel)

^g UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTACID AGENT; ANTI ACNE AGENT; ANTIASTHMATIC AGENT; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTITUSSIVE AGENT; CARDIOVASCULAR AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CIPROFLOXACIN; DIURETIC AGENT; OFLOXACIN; PLASMA SUBSTITUTE; PSYCHOTROPIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VASODILATOR AGENT;

ARTICLE; BACTERIAL INFECTION; BACTERIOLOGY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST MINIMIZATION ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG MONITORING; GREECE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ISRAEL; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SIDE EFFECT; SLOVENIA; TURKEY (REPUBLIC);

EID: 0030899309     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199711040-00007     Document Type: Article

References (10)

1. Bassaris H, Akalin E, Calangu S, et al. A randomised, multinational study with sequential therapy comparing ciprofloxacin twice daily and ofloxacin once daily. Infection 1995; 23: 227-33
2. Gyssens IC, Lennards CA, Hekster YA, et al. Cost of hospital antimicrobial chemotherapy: a method for global cost calculation. Pharm Weekbl Sci 1991; 13: 248-53
3. Kerr JR, Barr JG, Smyth ETM, et al. Technique for calculation of the true costs of antibiotic therapy. Eur J Clin Microbiol Infect Dis 1992; 11: 823-7
4. Duncan C, editor. UK Monthly Index of Medical Specialties, November. London: Haymarket Medical Ltd., 1994
5. Plumridge RJ. Cost comparison of intravenous antibiotic administration. Med J Aust 1990; 153: 516-8
6. Jewesson P. Cost-effectiveness and value of an IV switch. Pharmacoeconomics 1994; 5 Suppl. 2: 20-6
7. Rimmer P. Third generation cephalosporins in the parenteral to oral switch. Pharmacoeconomics 1994; 5 Suppl. 2: 27-33
8. Frighetto L, Bunz D, Martinusen S, et al. IV-PO step-down program: results of four years of experience. Ann Pharmacother 1992; 26: 1447-51
9. Lode H, Höffken G, Olschewski P, et al. Pharmacokinetics of ofloxacin after parenteral and oral administration. Antimicrob Agents Chemother 1987; 31: 1338-42
10. Bergan T, Thorsteinsson SB, Kolstad JM, et al. Pharmacokinetics of ciprofloxacin after intravenous and increasing oral doses. Eur J Clin Microbiol 1986; 5: 187-92